Skip to content

Revolutionary Breakthrough: Team Unlocks Potent Stem Cell Secret to Heal Damaged Hearts!




Understanding the Maturation of Heart Muscle Cells Derived from Human Stem Cells

Understanding the Maturation of Heart Muscle Cells Derived from Human Stem Cells

The Journey from Immature Fetal Stage to Mature Adult Form

A UCLA-led team has made a groundbreaking discovery that sheds light on the maturation process of heart muscle cells derived from human stem cells. This discovery can have significant implications for the development of new therapies for heart disease and heart damage. The findings, published in the peer-reviewed journal Circulation, contribute to our deeper understanding of how heart muscle cells progress from their immature fetal stage to their mature adult form.

RBFox1: An Essential Internal Control Mechanism

The collaborative effort between UCLA, Duke-NUS Medical School in Singapore, and other institutions has identified an RNA splicing regulator called RBFox1. This regulator is significantly more prevalent in adult heart cells compared to newborns, based on a preclinical model. The analysis of existing single-cell data confirmed the substantial increase of RBFox1 during cardiac cell maturation.

The team’s study leader, Jijun Huang, who conducted this research during his postdoctoral training in anesthesiology at UCLA, states, “This is the first evidence to suggest that the control of RNA splicing plays a vital role in the postnatal maturation of cardiac cells. While RBFox1 alone may not be sufficient to promote the complete maturation of fetal heart muscle cells, our findings reveal a novel internal RNA-based network that may significantly drive this maturation process beyond other available approaches.”

The Complex Maturation of Cardiac Muscle Cells

The transformation of cardiac muscle cells from birth to full maturity involves significant changes in their structure, functionality, and physiological properties. Up until now, it has been challenging to understand the mechanisms that oversee this comprehensive maturation process. This latest research breakthrough provides important insights into the mechanisms at play and paves the way for future therapeutic applications.

Unlocking the Potential of RNA Splicing Modulation

Although the precise mechanics of how RBFox1-mediated RNA splicing affect the maturation process and characteristics of cardiac muscle cells still require further exploration, this study demonstrates the proof of concept that modulation of RNA splicing can profoundly impact cardiomyocyte maturation. The researchers believe that this new knowledge opens doors to future therapeutic applications in the domains of cardiac regenerative therapy and disease modeling.

Advancing Cardiac Cell Maturation through RNA Splicing

Senior author Yibin Wang, who is also the director of the Duke-NUS Cardiovascular and Metabolic Disorders Program, emphasizes the significance of the findings, stating, “For the first time, we have shown that by simply altering RNA splicing, we can stimulate significant maturation of cardiac cells derived from human stem cells. These findings present a potential molecular approach to enhance cardiac cell maturation, which could address a major challenge in the domains of cardiac regenerative therapy and disease modeling.”

Funding and Collaborators

The study was funded by a Postdoctoral Award from the American Heart Association, the National Institutes of Health, and a Department of Defense Award. The research involved collaborative efforts from various institutions, including UCLA, Baylor College of Medicine, Vanderbilt University School of Medicine, Meharry School of Medicine, Forcyte Biotechnologies, the University of Cincinnati, the University of North Carolina, and the Agency for Science, Technology, and Research (A*STAR) in Singapore.

Insights and Perspectives

While the published study provides valuable insights into the role of RNA splicing in the maturation of heart muscle cells, it opens up avenues for further exploration and investigation. Here are some additional perspectives and practical examples that shed light on the topic:

RNA Splicing and Tissue Regeneration

The modulation of RNA splicing presents significant potential in the field of tissue regeneration. By manipulating RNA splicing regulators like RBFox1, scientists could potentially enhance the maturation of various other cell types derived from human stem cells, thereby advancing the field of regenerative medicine.

Personalized Medicine and Cardiac Disease Modeling

The ability to promote the maturation of cardiac cells derived from human stem cells offers promising opportunities for personalized medicine. With further research, scientists could potentially use patient-specific stem cells to model heart diseases and test the effectiveness of different treatments, leading to more targeted and efficient therapies.

RNA Splicing as a Therapeutic Target

The discovery of the crucial role of RNA splicing in cardiac cell maturation opens up the possibility of developing targeted therapies that aim to manipulate RNA splicing. By identifying specific molecular targets and developing interventions to modulate RNA splicing, researchers may be able to enhance the maturation of cardiac cells and improve outcomes for patients with heart disease.

Collaborative Research and Global Efforts

The collaborative nature of this study, involving institutions from different countries, highlights the importance of international collaboration in advancing scientific knowledge. The pooling of resources, expertise, and perspectives allows researchers to tackle complex questions and make significant discoveries that can benefit people worldwide.

Summary

A UCLA-led team has identified an essential internal control mechanism, RBFox1-mediated RNA splicing, that promotes the maturation of heart muscle cells derived from human stem cells. The study, published in the journal Circulation, unveils a novel network that significantly drives the maturation process. This groundbreaking research opens up new possibilities for therapies in heart disease and heart damage, with potential applications in personalized medicine and disease modeling. Collaborative efforts between institutions in different countries have contributed to this important research. While further exploration is needed, this discovery paves the way for future breakthroughs in cardiac regenerative therapy and offers hope for patients with heart disease.


—————————————————-

Article Link
UK Artful Impressions Premiere Etsy Store
Sponsored Content View
90’s Rock Band Review View
Ted Lasso’s MacBook Guide View
Nature’s Secret to More Energy View
Ancient Recipe for Weight Loss View
MacBook Air i3 vs i5 View
You Need a VPN in 2023 – Liberty Shield View

A UCLA-led team has identified an essential internal control mechanism that can promote the maturation of heart muscle cells derived from human stem cells, offering a deeper understanding of how heart muscle cells develop from their immature fetal stage. until its mature adult form.

The findings, published in the peer-reviewed journal. Circulationcould lead to new therapies for heart disease and heart damage.

The collaborative effort with Duke-NUS Medical School in Singapore and other institutions identified an RNA splicing regulator called RBFox1, which was significantly more prevalent in adult heart cells than in newborns, based on a preclinical model. The strong increase of RBFox1 during cardiac cell maturation was also confirmed by analysis of existing single-cell data.

“This is the first evidence to suggest that the control of RNA splicing plays a vital role in the postnatal maturation of cardiac cells,” said study leader Jijun Huang, who conducted this research during his postdoctoral training in anesthesiology at UCLA. . “While RBFox1 alone may not be sufficient to boost mature fetal heart muscle cells into fully mature adult cells, our findings uncover a novel internal RNA-based network that may substantially drive this maturation process beyond others. available approaches”.

The transformation of cardiac muscle cells from birth to full maturity involves significant changes in their structure, functionality and physiological properties. Until now, the mechanisms that oversee this comprehensive maturation have not been well understood.

Although the precise mechanics associating RBFox1-mediated RNA splicing with the resulting maturation procedures and characteristics still require further exploration, the study provides proof of concept that modulation of RNA splicing can profoundly affect cardiomyocyte maturation. This new knowledge suggests future therapeutic applications, pending additional research to expand on these initial findings.

“For the first time, we have shown that by simply altering RNA splicing, we can stimulate significant maturation of cardiac cells derived from human stem cells,” said senior author Yibin Wang, director of the Duke-NUES Cardiovascular and Metabolic Disorders Program. . “These findings present a potential molecular approach to enhance cardiac cell maturation, which could address a major challenge in the domains of cardiac regenerative therapy and disease modeling.”

The study was funded by a Postdoctoral Award from the American Heart Association (18POST33990469), the National Institutes of Health (R01 HL148714, R00 HL141626), and a Department of Defense Award (PR171540).

Co-authors of the study are Josh Lee, Christoph Rau, Dr. Arash Pezhouman, Tomohiro Yokota, Hiromi Miwa, Tsz Kin Kong, Shreya Udani, Chen Gao, Linsey Stiles, Dr. Orian Shirihai, Dr. Reza Ardehali and Dino Di Carlo of UCLA and others from Baylor College of Medicine, Vanderbilt University School of Medicine, Meharry School of Medicine, Forcyte Biotechnologies, the University of Cincinnati, the University of North Carolina, and the Agency for Science, Technology and Research (A*STAR) in Singapore.

—————————————————-